ANGPT2 and myocardial infarction: Angiopoietin-2 has also been shown to predict AKI in other patient populations, e.g., after myocardial infarction [47], after cardiopulmonary bypass [48], with acute respiratory distress syndrome [49], or among patients of intensive care unit [50].